INSP Earnings & Financial Statements
Inspire Medical Systems, Inc.
$69.01
+$0.94(+1.38%)
76
Overall
80
Value
90
Tech
60
Quality
Market Cap
$1.97B
Volume
186.36K
52W Range
$38.91 - $147.03
Target Price
$65.35
INSP earnings and financial statements: Inspire Medical Systems, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
INSP Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $911.98M | $802.80M | $624.80M | $407.86M | $233.39M |
| Cost of revenue | $133.22M | $122.99M | $96.58M | $66.11M | $33.28M |
| Operating income | $50.95M | $36.08M | -$40.27M | -$47.59M | -$39.85M |
| EBITDA | $79.79M | $65.03M | -$17.06M | -$40.73M | -$38.62M |
| Net income | $145.42M | $53.51M | -$21.15M | -$44.88M | -$42.04M |
| EPS (diluted) | $4.89 | $1.75 | $-0.72 | $-1.60 | $-1.54 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $907.32M | $808.38M | $676.81M | $564.88M | $295.08M |
| Total liabilities | $126.16M | $118.69M | $104.30M | $68.87M | $66.04M |
| Shareholders’ equity | $781.16M | $689.70M | $572.51M | $496.01M | $229.05M |
| Cash and equivalents | $104.81M | $150.15M | $185.54M | $441.59M | $214.47M |
| Long-term debt | $30.00M | $30.04M | $24.85M | $7.54M | $24.59M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $116.98M | $130.25M | $24.65M | $11.57M | -$20.12M |
| Capital expenditure | -$38.50M | -$39.12M | -$23.63M | -$9.10M | -$4.67M |
| Free cash flow | $78.48M | $91.12M | $1.02M | $2.47M | -$24.79M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INSP | $69.01 | +1.4% | 186.36K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Inspire Medical Systems, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW